For people with Parkinson's disease, higher levels of physical activity were associated with slower declines in thinking and ...

Patients who carry a mutation in the GBA1 gene—the most common genetic risk factor for Parkinson's disease—often experience ...

Trial found patients on solengepras had 37 minutes less ‘off’ time each day when dopamine drugs failed to work properly ...

Parkinson’s disease may begin with subtle changes in movement, sleep, digestion or smell. A visible tremor is a familiar sign ...

Researchers have carried out the first single-cell analysis of mitochondrial DNA in a population of brainstem neurons that ...

A new daily pill could help people with Parkinson’s disease live more of their life without symptoms, a trial has found.

At least 4 hours of moderate-to-vigorous exercise weekly was associated with slower cognition and motor decline over years of ...

The Takeda spinout showed that a high dose of solengepras can shorten the periods during which difficult Parkinson’s disease symptoms like involuntary movements and sleepiness.

Researchers at the University of Delaware have launched a new artificial intelligence institute aimed at developing ...

Data showed improvements in an objective measure of impaired eye movement associated with Parkinson’s disease, with a correlation between ...

A 2025 study found that men with a combination of three physical signs "had a 23-fold higher risk of receiving a [Parkinson's ...